
Tilray Brands, Inc.
- Jurisdiction
Canada - LEI
549300Y4V60733TO1478 - ISIN
US88688T1007 (TLRY )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
Profile
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€712.20M - Gross margin
28.6% - EBIT
-€625.10M - EBIT margin
-87.8% - Net income
-€814.70M - Net margin
-114.4%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
| N/A |
Dividends
No dividend payouts
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Gendel Mitchell | Global General Counsel |
|
|
|
|
Merton Carl A | Chief Financial Officer |
|
|
|
|
SIMON IRWIN D | President and CEO |
|
|
|
|